Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • NIAAA
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Social Sciences
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

Omicron variant

Ohio State logo

SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be a problem in the lung

The Omicron subvariants BA.1, BA.4, BA.5 as well as Q.1.1 have a high number of mutations in the spike protein. Some of these mutations are escape mutations that allow the virus to escape neutralization by antibodies. In addition, resistance to biotechnologically produced antibodies, which are administered to high-risk patients as a preventive measure or as therapy for a diagnosed SARS-CoV-2 infection, is also developing. Omicron sub-lineage BQ.1.1 is the first variant resistant to all antibody therapies currently approved by the EMA (European Medicines Agency) and/or FDA (US Food and Drug Administration).

New Omicron subvariant BQ.1.1 resistant to all therapeutic antibodies

Substack subscription form sign up

Comments

  • Sue Ann Hayes on Hidden Nuclear Protein Fuels Pancreatic Cancer’s Deadly Aggression
  • Curtis Webber on The GPS-Killer? This Quantum Device ‘Feels’ Motion Like a Brain—Down to the Atomic Level
  • Ran on How the Age You First Had Sex Could Shape How You Age Decades Later
  • Sparty on How the Age You First Had Sex Could Shape How You Age Decades Later
  • Josh Mitteldorf on A Single TV Segment Sent Leucovorin Prescriptions for Autistic Children Soaring 2,000 Percent
© 2026 ScienceBlog.com | Follow our RSS / XML feed